These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30796300)

  • 21. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
    Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M
    J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
    Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
    Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AT2 receptor stimulation inhibits phosphate-induced vascular calcification.
    Kukida M; Mogi M; Kan-No H; Tsukuda K; Bai HY; Shan BS; Yamauchi T; Higaki A; Min LJ; Iwanami J; Okura T; Higaki J; Horiuchi M
    Kidney Int; 2019 Jan; 95(1):138-148. PubMed ID: 30442332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
    Yamada S; Taniguchi M; Tokumoto M; Toyonaga J; Fujisaki K; Suehiro T; Noguchi H; Iida M; Tsuruya K; Kitazono T
    J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
    J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease.
    Gauthier-Bastien A; Ung RV; Larivière R; Mac-Way F; Lebel M; Agharazii M
    Clin Exp Hypertens; 2014; 36(3):173-80. PubMed ID: 23786435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.
    Vermeulen EA; Eelderink C; Hoekstra T; van Ballegooijen AJ; Raijmakers P; Beulens JW; de Borst MH; Vervloet MG
    Trials; 2022 Sep; 23(1):769. PubMed ID: 36096824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcification of the internal pudendal artery and development of erectile dysfunction in adenine-induced chronic kidney disease: a sentinel of systemic vascular changes.
    Maio MT; McCabe KM; Pruss CM; Pang JJ; Laverty K; Holden RM; Adams MA
    J Sex Med; 2014 Oct; 11(10):2449-65. PubMed ID: 25138987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.
    Khouzam N; Wesseling-Perry K
    Pediatr Nephrol; 2019 Jan; 34(1):1-10. PubMed ID: 28939921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease.
    Pai A; Leaf EM; El-Abbadi M; Giachelli CM
    Am J Pathol; 2011 Feb; 178(2):764-73. PubMed ID: 21281809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.
    Yao L; Sun YT; Sun W; Xu TH; Ren C; Fan X; Sun L; Liu LL; Feng JM; Ma JF; Wang LN
    Am J Nephrol; 2015; 41(1):28-36. PubMed ID: 25634106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats.
    Ishida K; Ashizawa N; Matsumoto K; Kobashi S; Kurita N; Shigematsu T; Iwanaga T
    J Bone Miner Metab; 2019 Sep; 37(5):796-804. PubMed ID: 30712064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease.
    Tani T; Orimo H; Shimizu A; Tsuruoka S
    Sci Rep; 2017 May; 7(1):2233. PubMed ID: 28533541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats.
    Kumata C; Mizobuchi M; Ogata H; Koiwa F; Kondo F; Kinugasa E; Akizawa T
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():18-22. PubMed ID: 21595847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification.
    Hou YC; Lu CL; Zheng CM; Chen RM; Lin YF; Liu WC; Yen TH; Chen R; Lu KC
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30642029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt/β-catenin pathway.
    Zhou P; Zhang X; Guo M; Guo R; Wang L; Zhang Z; Lin Z; Dong M; Dai H; Ji X; Lu H
    J Cell Mol Med; 2019 Oct; 23(10):7088-7098. PubMed ID: 31423730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical detection, risk factors, and cardiovascular consequences of medial arterial calcification: a pattern of vascular injury associated with aberrant mineral metabolism.
    Lau WL; Ix JH
    Semin Nephrol; 2013 Mar; 33(2):93-105. PubMed ID: 23465497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.